Howard Levy

Previously, he was CMO at Catalyst Biosciences, a Sr. Global Medical Program Director at CSL Bering, SVP & CMO at Inspiration Biopharmaceuticals, and Chief of Critical Care Medicine in the University of New Mexico. Also he was a former Clinical Research Physician and Medical Director, Acute Care, Eli Lilly and Company. He headed post-marketing clinical trials and medical affairs for recombinant Activated Protein C (Xigris) in severe sepsis.